Key facts
- This page summarizes R. Steven Hamner's Form 4 filing for MEDICAL PROPERTIES TRUST INC (MPW).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Apr 2025, 18:00.
R. Steven Hamner - 15 Apr 2025 Form 4 Insider Report for MEDICAL PROPERTIES TRUST INC (MPW)
- Reporting relationship
- Executive Vice President & CFO, Director
- Issuer ticker
- MPW
- Reported as of
- 15 Apr 2025
- Net transaction value
- -$21,554
- SEC form
- 4
- Accepted by SEC
- 17 Apr 2025, 18:00:07 UTC
- Prior SEC filing
- 03 Apr 2025
- Next SEC filing
- 08 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- W. Zachary Riddle, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
R. Steven Hamner filed Form 4 for MEDICAL PROPERTIES TRUST INC (MPW) on 17 Apr 2025.
Change
- Previous filing in this sequence was filed on 03 Apr 2025.
- Current net transaction value: -$21,554.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MPW
transaction
Common stock, par value $0.001
Tax liability
- Transaction value
- $21,554
- Shares
- -5,584
- Change %
- -0.22%
- Price
- $3.86
- Shares after
- 2,529,963
- Date
- 15 Apr 2025
- Ownership
- Direct
- Footnotes
- F1, F2
MPW
transaction
Common stock, par value $0.001
Award
- Transaction value
- $0
- Shares
- +494,026
- Change %
- +20%
- Price
- $0.000000
- Shares after
- 3,023,989
- Date
- 15 Apr 2025
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MPW
transaction
Derivative
Restricted common stock units
Award
- Transaction value
- $0
- Shares
- +207,020
- Change %
- +23%
- Price
- $0.000000
- Shares after
- 1,107,020
- Date
- 15 Apr 2025
- Ownership
- Direct
- Underlying class
- Common stock, par value $0.001
- Underlying amount
- 207,020
- Exercise price
- $0.000000
- Footnotes
- F4, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction.
Footnote F2
The total amount of securities beneficially owned following the reported transaction includes a decrease of 117,282 shares as a result of forfeitures related to previously disclosed share awards.
Footnote F3
Shares vest at the beginning of each calendar quarter ending March 31, 2028.
Footnote F4
The restricted stock units were granted under the Medical Properties Trust, Inc. ("the Company") Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified Company total shareholder return ("TSR") hurdles during the three-year period beginning April 15, 2025 (the "Grant Date") as follows: (i) if the Company's TSR reaches 20%, 100% of the restricted stock units will be earned; (ii) if the Company's TSR reaches 40%, 200% of the restricted stock units will be earned; and (iii) if the Company's TSR reaches 60%, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average, determined quarterly; provided, however, following the end of such three-year performance period, achievement of performance between specific TSR hurdles described above will be determined using straight line linear interpolation (continued on footnote 5).
Footnote F5
Earned restricted stock units will be settled in cash (based on the average price of the Company's common stock over the five trading days ending on the applicable vesting date) in equal quarterly installments over one year following the date the restricted stock units are earned, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding performance metrics following the end of the three-year performance period, subject to the grantee's continued employment through such date.